Newswise — ROSEMONT, Ill. (February 10, 2023)—The 2023 Kappa Delta Elizabeth Winston Lanier Award was presented to the Major Extremity Trauma Research Consortium (METRC) for its multi-disciplinary research platform addressing the challenging issues related to the evaluation, treatment and recovery after severe extremity trauma. This award recognizes research in musculoskeletal disease or injury with great potential to advance patient care. As the largest orthopaedic trauma research enterprise to date, METRC has conducted 34 studies, enrolled over 22,000 patients across 70 sites and published 57 papers, resulting in increased awareness and funding for extremity trauma care.
To read more about the award, please click here.
Highlights from the Research
During Operation Iraqi Freedom and Operation Enduring Freedom in Afghanistan, military orthopaedic surgeons were challenged with a surge of casualties with complex single or multiple extremity injures. While advanced field care and the use of body armor reduxced combat mortality, it increased the injury burden to the unprotected extremities. Critical challenges surfaced, including complex wound management, infection, bone and articular surface loss, blast-related heterotopic ossification, segmental nerve injury, volumetric muscle loss, acute compartment syndrome (ACS) and severe psychological stress that can complicate long-term recovery. At the same time, surgeons at Level I trauma centers across the country were experiencing similar challenges for treating civilian patients with high energy traumas, such as severe leg injuries with open fractures, bone loss, muscle and nerve damage, heavy contamination and compartment syndrome.
With lobbying support from the American Academy of Orthopaedic Surgeons (AAOS), the Department of Defense (DOD) requested proposals for an inaugural peer-reviewed consortium grant for Extremity War Injury research in 2008. Rather than submit competing applications, existing trauma research teams from the Lower Extremity Assessment Project (LEAP) study, the Southeast Fracture Consortium and the Orthopaedic Trauma Research Consortium worked together to develop an inclusive and unified approach, assembling top talent from around the country. As a result, METRC was formed, and in 2009 was awarded the DOD grant to establish a clinical research platform infrastructure and initiate prospective clinical research targeted to infection, ACS and bone healing.
“By establishing a military-civilian research collaboration, investigators could translate learnings across sectors, research could continue during interwar periods and the research dollars could benefit from an economy of scale by sharing resources and reducing the cost per study, while increasing productivity,” said Michael J. Bosse, MD, FAAOS, clinical chair emeritus of METRC.
METRC was anchored by a Data Coordinating Center at the Johns Hopkins Bloomberg School of Public Health and initially engaged clinical investigators at 20 Level I trauma centers and the four major military treatment facilities.
The success of the Consortium can be attributed to the following framework:
- Conducting randomized clinical trials and employing a “gaps driven” approach to define research that purposefully identifies challenging surgical and scientific questions
- Organizing a multi-center approach to conduct timely and clinically impactful research
- Developing a coordinated, standardized approach to protocol development and data collection
- Understanding that METRC’s growth allows for the design and execution of large pragmatic trials
- Establishing quality assessment and improvement strategies to learn, evolve and improve from each study
- Supporting individual participating investigators and academic centers to receive extremity trauma research funding
“We knew this initiative would not be successful unless we adopted a culture of collaboration among the researchers at our institutions,” said Ellen J. MacKenzie, PhD, METRC founding director of the Coordinating Center. “We worked hard to develop processes that were engaging, made everybody feel included, gave everybody a voice and recognized the collective accomplishments of the team.”
METRC selected seven research areas that were thought to be of highest importance in both military and civilian high energy trauma patients. These included:
- Prevention and management of acute and chronic musculoskeletal infections
- Early acute management of orthopaedic injury
- Reconstruction surgery and nonsurgical management to improve bone healing
- Prediction, prevention and amelioration of secondary conditions and long-term physical health effects
- Management of pain and psychosocial sequelae
- Rehabilitation interventions to improve functional outcomes and quality of life
- Amputation and limb salvage outcomes including optimization of prosthetics and orthotic devices
The Consortium’s research findings include:
- The Prevent CLOT study, the largest of the METRC research efforts, enrolled over 12,000 patients and showed that low dose aspirin was non-inferior to low-molecular-weight heparin in preventing death and was associated with a low incidence of deep-vein thrombosis and pulmonary embolism in the care of trauma patients with operatively treated extremity fractures or with any pelvic or acetabular fractures.
- The VANCO study, investigated an emerging low-cost topical wound antibiotic technique to reduce fracture-related infections by applying 1,000 mg of topical vancomycin to the wound prior to closure. The study demonstrated a 35% overall reduced risk of infection and a 50% reduction in gram positive infections. A study involving tobramycin targeting gram negative bacteria is currently underway.
- The Predicting Acute Compartment Syndrome studyiii sought to gain a better understanding of diagnostic standards for ACS, a challenging condition, as it is difficult to diagnose, can occur quickly and potentially lead to amputation or death. While more research is needed, in this study, near-infrared spectroscopy was unreliable for continuous measurement of tissue oxygenation in limbs with tibia fractures and was not able to reliably identify early changes in tissue oxygenation in patients at risk for ACS. Additionally, using a novel approach of having an expert panel review each case to determine whether ACS was present, the research highlighted a high incidence of unnecessary surgery when using a currently accepted standard of care to determine when fasciotomy is necessary (a surgery that is done emergently to reduce muscle pressure to maintain blood flow).
- The OUTLET study provided further analysis of the 2002 LEAP study cohort, which originally found that limb salvage and amputation provided similar outcomes for severe high energy trauma below the distal femur. Following reports of disappointing results from the salvage attempts of those patients with a severely injured distal tibia, ankle and/or foot, the OUTLET study found that for a subset of those with severe and complex foot and ankle injuries, early amputation was associated with a better outcome than the limb salvage patients.
“Over the past decade, the Consortium has grown to over 400 investigators, and what’s really impressive is the caliber of those who are involved,” said Dr. Bosse. “They are the who’s who in orthopaedic trauma in North America. Not only are they making game-changing discoveries, but they are training the next generation of residents, fellows and investigators, many of whom have gone on to start METRC-funded research centers.”
Since 2009, METRC has received $150 million in funding from the DOD, Patient Centered Outcomes Research Institute and National Institutes of Health.
“The real advantage of the Consortium has been the ability to leverage our resources across studies, which otherwise couldn’t have been conducted had it not been for the large multi-disciplinary team spanning numerous leading trauma centers across the country,” said Dr. MacKenzie. “The funding has helped us maintain the infrastructure at the coordinating center and clinical sites to conduct this research, and a continued investment will not only advance the care of injured service members in future conflicts but contribute to the medical readiness of current forces.”
# # #
About the Kappa Delta Awards
In 1947, at its golden anniversary, the Kappa Delta Sorority established the Kappa Delta Research Fellowship in Orthopaedics, the first award ever created to honor achievements in the field of orthopaedic research. The first annual award, a single stipend of $1,000, was made available to the AAOS in 1949 and presented at the AAOS meeting in 1950. The Kappa Delta Awards have been presented by the AAOS to persons who have performed research in orthopaedic surgery that is of high significance and impact.
The sorority has since added two more awards and increased the award amounts to $20,000 each. Two awards are named for the sorority national past presidents who were instrumental in the creation of the awards: Elizabeth Winston Lanier, and Ann Doner Vaughn. The third is known as the Young Investigator Award. For more information about the manuscript submission process, please visit aaos.org/kappadelta. Learn more about the Kappa Delta Foundation, here.
About the AAOS
With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world’s largest medical association of musculoskeletal specialists. The AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level to best treat patients in their daily practices. The AAOS is the source for information on bone and joint conditions, treatments and related musculoskeletal healthcare issues and it leads the healthcare discussion on advancing quality.
Follow the AAOS on Facebook, Twitter, LinkedIn and Instagram.
Disclosure
Funding and Conflicts of Interest
METRC has no conflicts of interests.
METRC Grants, Award Numbers, Prime Award Recipients:
DoD Consortium Award
METRC 1, W81XWH-09-2-0108, Johns Hopkins Bloomberg School of Public Health
METRC 2, W81XWH-10-2-0090, Johns Hopkins Bloomberg School of Public Health
METRC 3, W81XWH-16-2-0060, Johns Hopkins Bloomberg School of Public Health
DoD PRORP
SEXTANT, W81XWH-19-2-0062, Carolinas Medical Center
Stem Cell, W81XWH-18-2-0055, Johns Hopkins School of Medicine
TOBRA, W81XWH-19-1-0848, University of Maryland
UNION Biomarkers, W81XWH-19-1-0796, Boston Medical Center
VANCO, W81XWH-10-2-0134, University of Maryland
Weight Bearing, W81XWH-18-1-0810, Vanderbilt University Medical Center Mobility Tool Kit, W81XWH-18-1-0815, Carolinas Medical Center OXYGEN, W81XWH-12-1-0588, University of Maryland
POvIV, W81XWH-10-2-0133, Vanderbilt University Medical Center
POvIV II, TBD, Vanderbilt University Medical Center
PACS II, W81XWH-20-2-0050, Hennepin County Medical Center
PACS-PH, TBD, Hennepin County Medical Center
METALS II, W81XWH-15-2-0058, Johns Hopkins Bloomberg School of Public Health
NERVE, W81XWH-15-2-0074, Johns Hopkins School of Medicine
ProFit; W81XWH-14-1-0563, University of California San Francisco
PRIORITI – MTF, W81XWH-12-2-0032, Johns Hopkins Bloomberg School of Public Health
REPAIR, W81XWH-15-2-0067, Johns Hopkins Bloomberg School of Public Health
NSAIDS, W81XWH-20-2-0063, University of Utah
DoD AFIRM
Peg Fusion, W81XWH-20-1-0825, Johns Hopkins School of Medicine
NIH-NIAMS
STREAM, R01AR064066, Johns Hopkins Bloomberg School of Public Health
PCORI
Prevent Clot, PCS-1511-32745, University of Maryland School of Medicine
RSS